IL6 and major depressive disorder: The levels of plasma TNF-α (t=4.580, p<0.001) and IL-6 (z=-2.996, p<0.001) in MDD patients baseline and after treatment were higher than those in healthy controls, with no significant difference in biomarkers between baseline and after treatment (Table 3).